Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Michiels

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapyJ H Park, S F Jonas, G Bataillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine GlossaryL R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancerF Rothé, J-F Laes, D Lambrechts, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 6, 2024
Feasibility and Safety of the "One-Week Breast Radiation Therapy" ProgramM B Ba, F Giudici, C Bellini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialS Loi, S Michiels, R Salgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroupsC R Lindsay, V Faugeroux, S Michiels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 28, 2018
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapyS J Luen, R Salgado, M V Dieci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancerS Michiels, L Pugliano, S Marguet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapyJ H Park, S F Jonas, G Bataillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine GlossaryL R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancerF Rothé, J-F Laes, D Lambrechts, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 6, 2024
Feasibility and Safety of the "One-Week Breast Radiation Therapy" ProgramM B Ba, F Giudici, C Bellini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialS Loi, S Michiels, R Salgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroupsC R Lindsay, V Faugeroux, S Michiels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 28, 2018
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapyS J Luen, R Salgado, M V Dieci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancerS Michiels, L Pugliano, S Marguet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Pageof 6